Condition

Recurrent Small Cell Lung Cancer clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Autologous B7-H3 CAR T Cells in Advanced Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

  This study tests a patient’s own B7-H3 CAR T cells to see if they can help people 18 and older whose small cell lung cancer or EPNEC has come back or hasn’t responded to prior treatment.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07509034

• Biomarker-directed temozolomide plus stenoparib versus lurbinectedin for relapsed small cell lung cancer

  This trial tests whether adding the oral drug stenoparib to temozolomide works better than standard lurbinectedin for people with relapsed small cell lung cancer and whether a blood biomarker can help pick who will benefit.

  Recruiting at 6 sites Phase 1/2 VA Office of Research and Development · Palo Alto, California and 10 other locations · NCT06681220

Related topics

Quick answers

How many Recurrent Small Cell Lung Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →